JPH06256104A - Antibacterial action-sustaining disinfectant - Google Patents

Antibacterial action-sustaining disinfectant

Info

Publication number
JPH06256104A
JPH06256104A JP5042703A JP4270393A JPH06256104A JP H06256104 A JPH06256104 A JP H06256104A JP 5042703 A JP5042703 A JP 5042703A JP 4270393 A JP4270393 A JP 4270393A JP H06256104 A JPH06256104 A JP H06256104A
Authority
JP
Japan
Prior art keywords
limonene
antibacterial
disinfectant
effect
sterilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5042703A
Other languages
Japanese (ja)
Inventor
Yoshifumi Matsuda
善文 松田
Kinji Nakai
欣司 中井
Hiroshi Ebara
博 江原
Kazuhide Momoi
一英 桃井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HONSYU KOSAN KK
Original Assignee
HONSYU KOSAN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HONSYU KOSAN KK filed Critical HONSYU KOSAN KK
Priority to JP5042703A priority Critical patent/JPH06256104A/en
Publication of JPH06256104A publication Critical patent/JPH06256104A/en
Pending legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PURPOSE:To provide an antibacterial action-sustaining disinfectant having not only a sterilization effect but an antibacterial effect on the sterilized part even after sterilization and capable of maintaining an antibacterial effect especially even against MRSA. CONSTITUTION:A growth inhibitory effect of D-limonene, the main component of citrus peel oil on a bacterium such as colibacillus, Staphylococcus aureus or methicillin-resistant Staphylococcus aureus (MRSA), i.e. an antibacterial function is utilized. An antibacterial action especially even against MRSA is recognized. That is to say, a sterilization effect against bacteria and an antibacterial effect on the sterilized part are recognized by using an antibacterial action-sustaining disinfectant containing a medical germicide and limonene. In addition, in case the D-limonene content is >=0.8wt.% based on the total amount, the antibacterial effect is maintained after sterilization. It is recognized that an antibacterial effect is effective especially even against MRSA more preferably in the case of >=1.0wt.% D-limonene content based on the total amount.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、例えば細菌の発育を阻
止する特性いわゆる抗菌性を有するリモネンの特性を生
かした抗菌性持続型消毒剤に係り、より詳しくは抗菌性
が長期間持続し得る抗菌性持続型消毒剤に関するもので
ある。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibacterial and persistent disinfectant which takes advantage of, for example, the property of limonene having the property of inhibiting the growth of bacteria, so-called antibacterial property, and more specifically, the antibacterial property can be maintained for a long time. The present invention relates to an antibacterial persistent disinfectant.

【0002】[0002]

【従来の技術】近年、モダシン,アジセフ,メイセリン
等の第3世代セファム系の抗生物質を多量に投与した場
合、その抗生物質に対し耐性を有するようになった細菌
の出現が問題化している。例えば抵抗力が低下している
人体に対し敗血症等を誘発し、最悪の場合致命的な影響
を及ぼすメチシリン耐性黄色ブドウ球菌(Methic
illin−resistant Staphyloc
occus aureus:以下、MRSAと略称す
る)による病院での院内感染が大きな社会問題になって
いる。このMRSAによる症状を抑制するために、抗生
物質を更に投与したとしても有効でないのは明らかであ
る。そこで、このMRSAに対する応急措置として、病
室内にクレゾール等を散布したり、或いは室内備品例え
ばドアのノブ,ベッドの手すり等を消毒用アルコールに
て拭いたりするといった殺菌処理が施されている。
2. Description of the Related Art In recent years, when a large amount of third-generation cepham antibiotics such as modacin, adicef, and macerin are administered, the emergence of bacteria that have become resistant to the antibiotics has become a problem. For example, methicillin-resistant Staphylococcus aureus (Methic) induces sepsis or the like in a human body with reduced resistance and has a fatal effect in the worst case.
illin-resistant Staphyloc
Nosocomial infections in hospitals due to occus aureus (hereinafter, abbreviated as MRSA) have become a major social problem. It is clear that further administration of antibiotics is not effective for suppressing the MRSA-induced symptoms. Therefore, as an emergency measure against this MRSA, sterilization treatment such as spraying cresol or the like into the hospital room or wiping indoor equipment such as door knobs and handrails of beds with rubbing alcohol is performed.

【0003】ところで、樹木から発散される天然物たる
テルペン類は、悪臭を隠ぺいするマスキング性や種々の
生物学的特性を有することが知られている。これらのテ
ルペン類は、概して(C1016n の構造式(詳しくは
イソプレンC5 8 を基本単位とする)で表される。上
記テルペン類のうち、モノテルペンの一種であるリモネ
ン(1−Methyl−4−(1−methyleth
enyl)cyclohexene;C10 16)は光学
活性を有する天然物であって、沸点(B.P763 )17
5〜176.5℃,比重(d4 20.85)0.8402,屈
折率(nD )1.4744,引火点45℃等の物性、及
び水に不溶でアルコールに微溶等の溶解性を有してい
る。このリモネンのうち、D体はオレンジ皮油(約90
wt%含有),ミカン皮油(約90wt%含有),又は
レモン皮油(約87wt%含有)等のいわゆる柑橘皮油
に含まれており、米国のFDAテスト合格物質であって
国内でも食品添加物としての使用が認められている。な
お、上記テルペン類の生物学的特性としては、例えば殺
菌性,殺虫性,去痰性,鎮静性,利尿性,芳香性或いは
除虫性(この除虫性は所謂フィトンチッド性ともいう)
等が挙げられる。これらのうち、殺菌性には、注目すべ
きものがある。例えば、神山等は、D−リモネンを約8
7wt%含むとされるレモン皮油がフェノールと比べて
5.2倍の殺菌力を有すると報告している(出典;書籍
名“ブルーバックス「植物の不思議な力=フィトンチッ
ド」”,昭和55年4月20日発行,講談社出版)。
By the way, a natural product emanating from a tree
Terpenes have a variety of masking properties to mask offensive odors and various
It is known to have biological properties. These te
Rupen is generally (CTenH16)nStructural formula of
Isoprene CFiveH8Is the basic unit). Up
Limonet, a type of monoterpene among terpenes
(1-Methyl-4- (1-methyleth
enyl) cyclohexene; CTenH 16) Is optical
It is a natural product having activity and has a boiling point (BP763) 17
5 to 176.5 ° C, specific gravity (dFour 20.85) 0.8402
Folding rate (nD) 1.4744, physical properties such as flash point 45 ° C, and
Insoluble in water and slightly soluble in alcohol
It Of this limonene, D-form is orange peel oil (about 90
wt%), mandarin orange oil (containing about 90 wt%), or
So-called citrus peel oil such as lemon peel oil (containing about 87 wt%)
And is a substance that has passed the FDA test in the United States.
It is also approved as a food additive in Japan. Na
The biological properties of the above terpenes include, for example, killing.
Fungal, insecticidal, expectorant, sedative, diuretic, aromatic or
Insecticidal (this insecticidal property is also called phytoncide)
Etc. Of these, bactericidal properties should be noted.
There are kimonos. For example, Kamiyama et al.
Compared to phenol, lemon peel oil is said to contain 7 wt%
It has been reported to have 5.2 times the bactericidal power (Source: Book
Name "Blue Bucks" The mysterious power of plants = Phitton
"", Published April 20, 1980, published by Kodansha).

【0004】[0004]

【発明が解決しようとする課題】上記のように特有の殺
菌性を有するにもかかわらず、従来よりリモネンは柑橘
系の香料の主用途で用いられている。例えば、米国では
一般には1940年代以降より、石鹸、洗浄剤、クリー
ムローション又は香水等の各種製品に0.005〜1.
0wt%の濃度範囲で香料として使用されてきた。これ
は、このような天然物を使用しなくても、病院等で用い
られる殺菌剤としては、アルコール,フェノール,クレ
ゾール,ホルマリン又はヨード系等の工業製品を用いた
方が簡便であること、即ち天然物の場合原料の入手や量
確保が困難であると考えられていたこと、或いは組成中
のリモネン濃度が極めて高い場合は柑橘臭がきついこと
等に起因したものである。ところで、上記工業製品の殺
菌剤を用いる場合、例えばアルコールを用いて被殺菌部
を払拭すると、極めて強力に殺菌することができる。し
かしながら、アルコールが被殺菌部から蒸散したのちは
殺菌力がなくなり、この被殺菌部に細菌が再付着すると
細菌の増殖を防ぐことができないため、いわゆる抗菌性
がほとんど持続しないという欠点があった。一方、D−
リモネンは、ミカン皮やレモン皮の柑橘皮油中に多量に
含まれており、ミカンジュースやレモンジュースの製造
時に排出される柑橘皮を圧搾し蒸留することにより、比
較的大量且つ容易に得ることができる。
In spite of the peculiar bactericidal property as described above, limonene has hitherto been used mainly for citrus flavors. For example, generally in the United States since the 1940s, various products such as soaps, detergents, cream lotions, and perfumes have been added to 0.005-1.
It has been used as a fragrance in the concentration range of 0 wt%. This means that it is easier to use industrial products such as alcohol, phenol, cresol, formalin or iodine as a bactericide used in hospitals without using such natural products, that is, In the case of natural products, it was considered that it was difficult to obtain the raw materials and secure the amount thereof, or when the limonene concentration in the composition was extremely high, the citrus odor was strong. By the way, in the case of using the above-mentioned industrial product sterilizing agent, if the portion to be sterilized is wiped with, for example, alcohol, it can be sterilized extremely strongly. However, there is a drawback that the so-called antibacterial property hardly lasts because the bactericidal power is lost after the alcohol is evaporated from the sterilized portion and the bacteria cannot be prevented from growing if the bacteria reattach to the sterilized portion. On the other hand, D-
Limonene is contained in a large amount in citrus peel oil of orange peel and lemon peel, and can be obtained in a relatively large amount and easily by pressing and distilling citrus peel discharged during the production of orange juice and lemon juice. You can

【0005】そこで、本発明者等は、従来技術のかかる
問題点を解決するため種々検討を重ねた結果、被消毒部
の殺菌消毒はもとより、殺菌消毒後の被消毒部における
抗菌性が長く持続する消毒剤に関して鋭意研究を行い、
細菌類、特にMRSAに対しても抗菌性が持続し得る抗
菌性持続型消毒剤を提供するに至った。
The inventors of the present invention have conducted various studies to solve the above problems of the prior art. As a result, not only the sterilization and disinfection of the sterilized portion but also the antibacterial property of the sterilized and disinfected portion continues for a long time. We conducted diligent research on disinfectants to
It has come to provide an antibacterial persistent disinfectant capable of sustaining antibacterial properties against bacteria, especially MRSA.

【0006】[0006]

【課題を解決するための手段】本発明者等は実験を通じ
て、柑橘皮油の主成分たるD−リモネンが大腸菌,黄色
ブドー球菌,又はメチシリン耐性黄色ブドー球菌(MR
SA)等の細菌類に対しその発育を阻止する特性、即ち
抗菌性の機能があることを確認した。特に、MRSAに
対しても抗菌性が認められ、このMRSAによる社会問
題を解決し得る発明を完成した。すなわち、本発明者等
は、医療用殺菌剤とリモネンとを含んでなる抗菌性持続
型消毒剤が、被消毒部の細菌に対する殺菌性と抗菌性と
を有し得ることを解明したのである。また、抗菌性持続
型消毒剤中のリモネンの含有量が少なくとも全体の0.
8wt%以上である場合には、殺菌後に主としてリモネ
ンによって抗菌性を持続させることができ、より好まし
くは全体の1.0wt%以上である場合には、特にMR
SAに対しても有効な抗菌効果を奏することを解明し
た。一方、上記リモネンの含有量が多いほど、リモネン
自体による殺菌効果を得ることができる。しかしなが
ら、リモネンの含有量が多過ぎると、医療用殺菌剤に対
するリモネンの分散性が悪く実用的でないことや当該消
毒剤からの柑橘臭がきつく却って不快感を与えることに
なるので、リモネンの実用的な含有量としては医療用殺
菌剤とリモネンとが比較的容易に分散され得るとともに
心地よい柑橘香を発する製品を得ることのできる量まで
に留めておくのが好ましい。更に、上記医療用殺菌剤が
常温下又は体温下にて蒸発するものである場合、この医
療用殺菌剤は被消毒部から経時的に蒸散するが、この蒸
散によってリモネンが濃縮される。
Means for Solving the Problems Through the experiments, the present inventors have found that D-limonene, which is the main component of citrus peel oil, can be transformed into Escherichia coli, Staphylococcus aureus, or methicillin-resistant Staphylococcus aureus (MR).
It was confirmed that bacteria such as SA) have a property of inhibiting the growth thereof, that is, an antibacterial function. In particular, antibacterial properties were also recognized against MRSA, and the invention that could solve the social problems caused by MRSA was completed. That is, the present inventors have clarified that an antibacterial and persistent disinfectant containing a medical disinfectant and limonene can have bactericidal and antibacterial properties against bacteria in the disinfected portion. Further, the content of limonene in the antibacterial persistent disinfectant is at least 0.
When it is 8 wt% or more, the antibacterial property can be maintained mainly by limonene after sterilization, and more preferably 1.0 wt% or more of the whole, especially MR
It was clarified that it also has an effective antibacterial effect against SA. On the other hand, as the content of limonene is higher, the bactericidal effect of limonene itself can be obtained. However, if the content of limonene is too high, the dispersibility of limonene in a medical disinfectant is poor and not practical, and the citrus odor from the disinfectant causes a rather unpleasant feeling, which makes the limonene practical. It is preferable that the content of the medical bactericide and limonene be relatively easily dispersed, and that the content of the product yields a pleasant citrus scent. Further, when the medical bactericidal agent evaporates at room temperature or body temperature, the medical bactericidal agent evaporates with time from the portion to be sterilized, and this evaporation causes the limonene to be concentrated.

【0007】[0007]

【作用】本発明にいう医療用殺菌剤としては、殺菌作用
を有する例えばエチルアルコール,iso−プロピルア
ルコール,フェノール,クレゾール,ホルマリン,ヨー
ド系等及びそれらの水溶液を挙げることができる。ま
た、本発明にいう医療用殺菌剤としてより好ましくは、
常温下又は体温下にて蒸発しこれによってリモネンが経
時的に濃縮するものがよい。上記のようなより好ましい
医療用殺菌剤としては、例えば汎用のエチルアルコール
70wt%水溶液,iso−プロピルアルコール(沸点
(常圧下)=97℃)又はその水溶液(日本薬局方)等
が挙げられる。本発明にいうリモネンとしては、光学活
性の面から分類されるD体,L体,又はDL体のいずれ
を用いてもよいが、より好ましくはジュース工場から排
出されるミカン皮等から比較的大量且つ容易に入手でき
るD−リモネンを用いるのがよい。上記リモネンは、い
わゆる非共役型のテルペン系炭化水素であって、水やア
ルコール等に対する親和性が比較的小さくこれらの混合
物は均一に分散しにくいが、密封容器内に収容した上記
混合物を使用直前に激しく振盪してゾル状に分散させた
状態で使用すれば足りる。また、これらの混合物に対し
適当量の界面活性剤を添加すれば、均一に可溶化したも
のを用いることもできる。従って、本発明による抗菌性
持続型消毒剤を被消毒部に対して塗抹したり或いは吹き
付ければ、先ず医療用殺菌剤の作用により被消毒部が殺
菌消毒される。その後、当該被消毒部に細菌が新たに付
着しても、上記医療用殺菌剤により殺菌されるか又はリ
モネンの作用によりこの細菌の発育が阻止される。ま
た、医療用殺菌剤が常温下又は体温下にて蒸発するもの
である場合、この医療用殺菌剤が被消毒部から経時的に
蒸散したとしても、この蒸散によってリモネンが濃縮さ
れるので、最終的には細菌の発育を阻止し且つ殺菌作用
をも有するリモネン液膜が被消毒部に形成される。
The medical bactericidal agent referred to in the present invention includes, for example, ethyl alcohol, iso-propyl alcohol, phenol, cresol, formalin, iodide and the like and their aqueous solutions having a bactericidal effect. Further, more preferably as a medical bactericidal agent according to the present invention,
It is preferable to evaporate the limonene at room temperature or body temperature so that limonene is concentrated over time. Examples of the more preferable medical disinfectant as described above include a general-purpose ethyl alcohol 70 wt% aqueous solution, iso-propyl alcohol (boiling point (under normal pressure) = 97 ° C.), or its aqueous solution (Japanese Pharmacopoeia). As the limonene referred to in the present invention, any of D-form, L-form, and DL-form classified from the aspect of optical activity may be used, but more preferably, a relatively large amount is obtained from mandarin orange peel discharged from a juice factory. It is preferable to use D-limonene which is easily available. The limonene is a so-called non-conjugated terpene hydrocarbon, which has a relatively small affinity for water, alcohol and the like, and a mixture thereof is difficult to uniformly disperse, but the mixture contained in a sealed container is used immediately before use. It is sufficient to use it in the state of being dispersed in a sol by vigorously shaking it. Further, a uniformly solubilized product can be used by adding an appropriate amount of a surfactant to these mixtures. Therefore, when the antibacterial continuous disinfectant according to the present invention is smeared or sprayed on the disinfected area, the disinfected area is first sterilized by the action of the medical disinfectant. After that, even if bacteria are newly attached to the disinfected part, the bacteria are sterilized by the medical disinfectant or the growth of the bacteria is prevented by the action of limonene. Further, when the medical bactericidal agent is one that evaporates at room temperature or body temperature, even if this medical bactericidal agent evaporates over time from the sterilized part, limonene is concentrated by this evaporation, so the final Specifically, a limonene liquid film that inhibits the growth of bacteria and also has a bactericidal action is formed on the disinfected portion.

【0008】本発明者等は、本発明の抗菌性持続型消毒
剤の効能と社会事情との関連についても多くの研究を行
った結果、本発明の抗菌性持続型消毒剤を広範な分野で
応用できることを見出した。例えば、皮膚の消毒用、
器具,用具,繊維,ガーゼ付きバンソウコウ,衣服等
の消毒用、消毒剤含浸手拭き用ナフキン、病院,養
護施設等の院内設備の消毒用(院内感染の阻止用)、
理容,美容施設での消毒用、公共施設での消毒用、
公共性遊戯場(例えば、パチンコ,ゲーム場等)の消毒
用として活用することができる。即ち、本発明の抗菌性
持続型消毒剤は、これを例えば紙,布或いはモップ等の
被含浸物に含浸させて被消毒部を擦拭すれば、医療用殺
菌剤により被消毒部を確実に殺菌でき、殺菌後は上記被
消毒部に新たに付着した細菌の発育・増殖をも阻止する
こともできるので、社会問題と化している例えばMRS
Aによる院内感染の蔓延防止に極めて有効である。
The present inventors have conducted many researches on the relationship between the efficacy of the antibacterial persistent disinfectant of the present invention and social circumstances, and as a result, the antibacterial persistent disinfectant of the present invention has been widely applied. I found that it can be applied. For example, for disinfecting skin,
Tools, tools, textiles, gauze swallows, disinfection of clothes, disinfectant-impregnated hand towels, disinfection of hospital equipment such as hospitals and nursing homes (to prevent nosocomial infections),
For barber, disinfection in beauty facilities, disinfection in public facilities,
It can be used for disinfecting public amusement parks (eg, pachinko machines, game arcades, etc.). That is, the antibacterial persistent disinfectant of the present invention can be sterilized by a medical disinfectant without fail by impregnating the impregnated material such as paper, cloth or mop and rubbing the disinfected area. After the sterilization, it is possible to prevent the growth and multiplication of bacteria newly attached to the disinfected part, which is a social problem. For example, MRS.
It is extremely effective in preventing the spread of nosocomial infection by A.

【0009】[0009]

【実施例】本発明の技術内容を明確にするため、以下に
示す代表的な実施例により本発明を具体的に説明する。
尚、以下の実施例は本発明を具体化した単なる例に過ぎ
ず、本発明の技術的範囲を限定するものでないのは無論
である。
EXAMPLES In order to clarify the technical contents of the present invention, the present invention will be specifically described by the following representative examples.
In addition, it is needless to say that the following embodiments are merely examples embodying the present invention and do not limit the technical scope of the present invention.

【0010】実施例1.本実施例に係る抗菌性持続型消
毒剤は、これに含まれる医療用殺菌剤の強力な殺菌作用
を元来より有するため、これを試験用の検体としてその
まま用いると、細菌類は培養初期に悉く死滅してしま
う。そこで、殺菌後の医療用殺菌剤が被消毒部から蒸散
してリモネンが残存した状況を想定し、リモネンのみを
上記検体として用いて細菌類を培養し、その発育を観察
した。 (1)「試験概要」 リモネンとしては、D−リモネンを用い、このD−リモ
ネンを任意濃度に希釈して添加した寒天平板培地に接種
用菌液を塗抹して培養した後、菌の発育を阻止し得た最
低の任意濃度をもって最小発育阻止濃度とした。測定に
供したD−リモネンの任意濃度としては、滅菌精製水で
希釈した0.01wt%,0.1wt%及び1.0wt
%の3種類の濃度とした。 (2)「試験方法」 1)試験菌株 試験菌株としては、例えば大腸菌(Escherich
is coli IFO 12734),黄色ブドウ球
菌(Staphylococcus aureus I
FO 12732),MRSA(Methicilli
n−resistant Staphylococcu
s aureus)を用いた。 2)増菌用培地及び希釈用培地 増菌用培地及び希釈用培地としては、例えばミューラー
・ヒントン・ブロス(Mueller Hinton
Broth(Difco))を用いた。 3)感受性測定用培地 感受性測定用培地としては、例えばミューラー・ヒント
ン・ミディアム(Mueller Hinton Me
dium(Difco))を用いた。 4)感受性測定用平板の調製 ジメチルスルホキシドを溶媒として用い、検体としてD
−リモネン単体の20%(wt(溶質)/vol(溶
媒))溶液を調整した後、さらにこの溶液をもとに滅菌
精製水で2倍希釈系列液を調製した。均一に溶解させた
後、約50℃に保った上記感受性測定用培地に対し各希
釈液をそれぞれ1/9量加えて充分に混合した後、複数
のシャーレに分注し、それぞれを固化させて感受性測定
用平板とした。尚、試験対照サンプルとして検体無添加
の平板も調製した。 5)接種用菌液の調製 接種用菌液としては、各試験菌株を増菌用培地で35℃
で18〜20時間培養した後、希釈用培地を用いて菌数
が約106 /mlとなるように調製した。 6)培養 上記接種用菌液を付着させたニクロム線ループ(ループ
内径約1mm)を用いて、この接種用菌液を感受性測定
用平板に2cm程度画線塗抹し、35℃で18〜20時
間培養した。 7)判定 上記培養後に、各試験菌株の発育を観察し、発育が阻止
された最低の任意濃度をもって各試験菌株に対する最小
発育阻止濃度とした。 8)判定結果 その判定結果を以下の表1に示す。表1から明らかなよ
うに、D−リモネン濃度が、0.01wt%及び0.1
wt%の検体を用いた場合はいずれの菌についても、そ
の発育を阻止できず、抗菌性が認められなかった。しか
しながら、1.0wt%の場合はいずれの菌について
も、その発育を阻止することができ、抗菌性が認められ
た。即ち、1.0wt%のD−リモネン濃度を最小発育
阻止濃度とした。
Embodiment 1. The antibacterial continuous disinfectant according to the present example originally has a strong bactericidal action of the medical disinfectant contained therein, and therefore, when it is used as a test sample as it is, bacteria are cultivated in the initial stage of culture. It will die in a rage. Therefore, assuming the situation that the medical sterilizing agent after sterilization was evaporated from the disinfecting portion and limonene remained, the bacteria were cultured using only limonene as the above sample, and the growth thereof was observed. (1) "Test outline" D-limonene was used as the limonene, and the agar plate medium to which this D-limonene was diluted at an arbitrary concentration was added to the agar plate medium to inoculate it, followed by culturing. The lowest arbitrary concentration that could be inhibited was defined as the minimum inhibitory concentration. As an arbitrary concentration of D-limonene used for measurement, 0.01 wt%, 0.1 wt% and 1.0 wt diluted with sterile purified water were used.
%, And three concentrations were used. (2) "Test method" 1) Test strain As a test strain, for example, Escherichia coli (Escherich
is coli IFO 12734), Staphylococcus aureus I
FO 12732), MRSA (Methicilli)
n-resistant Staphylococcu
aureus) was used. 2) Enrichment medium and dilution medium Examples of the enrichment medium and the dilution medium include, for example, Mueller Hinton Broth (Mueller Hinton).
Broth (Difco)) was used. 3) Susceptibility measuring medium As a sensitivity measuring medium, for example, Mueller Hinton Medium (Mueller Hinton Me
dium (Difco)) was used. 4) Preparation of plate for sensitivity measurement D was used as a sample by using dimethyl sulfoxide as a solvent.
After preparing a 20% (wt (solute) / vol (solvent)) solution of limonene simple substance, a 2-fold dilution series solution was further prepared with sterile purified water based on this solution. After being uniformly dissolved, 1/9 amount of each diluted solution was added to the sensitivity measurement medium maintained at about 50 ° C. and mixed sufficiently, and then dispensed into a plurality of petri dishes to solidify each. The plate was used for sensitivity measurement. A plate without a sample was also prepared as a test control sample. 5) Preparation of bacterial solution for inoculation As a bacterial solution for inoculation, each test strain was added to a culture medium for enrichment at 35 ° C.
After culturing for 18 to 20 hours, the medium was used for dilution so that the number of bacteria was adjusted to about 10 6 / ml. 6) Culturing Using a nichrome wire loop (loop inner diameter of about 1 mm) to which the inoculum bacterial solution is adhered, the inoculum bacterial solution is streaked for about 2 cm on a susceptibility measuring plate, and at 35 ° C. for 18 to 20 hours. Cultured. 7) Determination After the above culture, the growth of each test strain was observed, and the lowest arbitrary concentration at which the growth was inhibited was defined as the minimum growth inhibitory concentration for each test strain. 8) Judgment result The judgment result is shown in Table 1 below. As is clear from Table 1, the D-limonene concentration was 0.01 wt% and 0.1%.
When the wt% sample was used, the growth of any of the bacteria could not be prevented and no antibacterial property was observed. However, in the case of 1.0 wt%, the growth of any of the bacteria could be inhibited, and antibacterial properties were recognized. That is, the D-limonene concentration of 1.0 wt% was defined as the minimum inhibitory concentration.

【0011】[0011]

【表1】 [Table 1]

【0012】上記したように、添加量1.0wt%で最
小発育阻止濃度となるD−リモネンの特性を生かすため
に、本実施例の「抗菌性持続型消毒剤」を次に示す組成
にて調製した。1〜10wt%のD−リモネン又はこの
D−リモネン1〜10wt%に相当する当量の柑橘皮油
と、0.2wt%の非イオン界面活性剤と、汎用の消毒
用エチルアルコール(約70wt%の水溶液を用い、全
体を100wt%とした場合の残分)とを混合し、かき
混ぜて均一に分散溶解させることにより、殺菌性を備え
た抗菌性持続型消毒剤を得た。そこで、上記D−リモネ
ンを含む抗菌性持続型消毒剤を用いて、被消毒部たる皮
膚や器具を拭いたり又はガーゼ等の繊維に含ませると、
抗菌性持続型消毒剤中の消毒用エチルアルコールにより
それらの殺菌が行われる。そして、殺菌後にそのまま風
乾させると、消毒用エチルアルコールが被消毒部から蒸
散し、D−リモネンが経時的に濃縮される。これによっ
て、皮膚面,器具類や衣類繊維の表面に、抗菌性はもと
より殺菌性をも有するD−リモネンの液膜が形成され
る。このように、アルコール消毒された被消毒部のD−
リモネンの液膜は、濃縮により大腸菌、黄色ブドー球菌
・MRSA等に対する殺菌・抗菌性が徐々に増大する。
また、D−リモネンは常温では蒸発しにくく被消毒部に
長期的に残留するため、細菌が付着してもその細菌の発
育・増殖を長期間阻止することができる。更に、リモネ
ンは人の皮膚組織に対して保湿作用を奏するため、例え
ばこの抗菌性持続型消毒剤で手指を払拭して消毒用エチ
ルアルコールが蒸散した後は、リモネンの作用により手
指がスベスベするといった快適感を与えることができ
る。
As described above, in order to make the most of the characteristic of D-limonene which becomes the minimum inhibitory concentration when the added amount is 1.0 wt%, the "antibacterial continuous disinfectant" of the present embodiment has the following composition. Prepared. 1-10 wt% D-limonene or an equivalent amount of citrus peel oil corresponding to 1-10 wt% of this D-limonene, 0.2 wt% nonionic surfactant, and general-purpose disinfecting ethyl alcohol (about 70 wt% An aqueous solution was used, and the mixture was mixed with 100% by weight of the total amount), and the mixture was stirred to uniformly disperse and dissolve, thereby obtaining an antibacterial continuous disinfectant having bactericidal properties. Therefore, by using the antibacterial persistent disinfectant containing D-limonene described above, the skin or equipment as the portion to be disinfected can be wiped or contained in fibers such as gauze,
They are sterilized by the disinfecting ethyl alcohol in the antibacterial persistent disinfectant. When sterilized and air-dried as it is, ethyl alcohol for disinfection evaporates from the portion to be disinfected and D-limonene is concentrated over time. As a result, a liquid film of D-limonene having not only antibacterial properties but also bactericidal properties is formed on the skin surface, surfaces of appliances and clothing fibers. In this way, the D-
The liquid film of limonene gradually increases its bactericidal and antibacterial properties against Escherichia coli, Staphylococcus aureus, MRSA, etc. due to concentration.
Moreover, since D-limonene is hard to evaporate at room temperature and remains in the disinfecting area for a long time, growth and growth of the bacteria can be prevented for a long time even if the bacteria adhere. Furthermore, since limonene exerts a moisturizing action on human skin tissue, for example, after wiping the fingers with this antibacterial antiseptic disinfectant and evaporating ethyl alcohol for disinfection, the action of limonene causes the fingers to become smooth. You can give a feeling of comfort.

【0013】参考例1.上記被消毒部の殺菌・抗菌効果
に加えて、当該被消毒部の汚れ落とし効果をも考慮した
場合の適用例を想定し、次に示す組成のD−リモネン含
有乳液を調製し、上記実施例1と同様に各試験菌種に対
する抗菌性を観察した。 「D−リモネン含有乳液の組成」 ・柑橘皮油(D−リモネン90wt%含有) 40.5wt% ・乳化剤A(ソルビタン脂肪酸エステル) 7.1wt% ・乳化剤B(ポリオキシエチレンソルビタン 脂肪酸エステル) 7.4wt% ・乳化剤C(ポリオキシエチレンノニル フェニルエステル) 4.1wt% ・基材(精製水=イオン交換水) 40.8wt% ・pH調製剤(重炭酸ソーダ) 0.1wt% 組成合計 100.0wt% 「D−リモネン含有乳液の調製」精製水408gに、ポ
リオキシエチレンソルビタン脂肪酸エステル74g,ソ
ルビタン脂肪酸エステル71g,ポリオキシエチレンノ
ニルフェニルエステル41gを加え、これらをかき混ぜ
て均一に溶解させる。次に、柑橘皮油(D−リモネン9
0wt%含有)405gを加え、粘ちょうで均一なエマ
ルジョン液になるまでかき混ぜる。このエマルジョン液
のpH値を重炭酸ソーダを用いて6〜7に調整し、上記
D−リモネン含有乳液(クレンジング乳液)を調製し
た。
Reference Example 1. In addition to the sterilization / antibacterial effect of the disinfected area, an application example in which the stain removing effect of the disinfected area is also taken into consideration, and a D-limonene-containing emulsion having the following composition is prepared, In the same manner as in 1, the antibacterial activity against each test bacterial species was observed. "Composition of emulsion containing D-limonene" -Citrus peel oil (containing 90 wt% D-limonene) 40.5 wt% -Emulsifier A (sorbitan fatty acid ester) 7.1 wt% -Emulsifier B (polyoxyethylene sorbitan fatty acid ester) 7. 4 wt% -Emulsifier C (polyoxyethylene nonyl phenyl ester) 4.1 wt% -Base material (purified water = ion-exchanged water) 40.8 wt% -pH adjuster (sodium bicarbonate) 0.1 wt% Total composition 100.0 wt% Preparation of D-Limonene-Containing Emulsion "To 408 g of purified water, 74 g of polyoxyethylene sorbitan fatty acid ester, 71 g of sorbitan fatty acid ester, and 41 g of polyoxyethylene nonylphenyl ester are added, and they are stirred to dissolve uniformly. Next, citrus peel oil (D-limonene 9
405 g (containing 0 wt%), and stir until a viscous and uniform emulsion liquid is obtained. The pH value of this emulsion was adjusted to 6 to 7 with sodium bicarbonate to prepare the D-limonene-containing emulsion (cleansing emulsion).

【0014】(1)「試験概要」 検体としてD−リモネン単体の代わりに上記D−リモネ
ン含有乳液を用いた以外は、このD−リモネン含有乳液
を任意濃度に希釈して添加した寒天平板培地に接種用菌
液を塗抹して培養した後、菌の発育を阻止し得た最低の
任意濃度をもって最小発育阻止濃度とするのは、実施例
1と同様である。測定に供したD−リモネン含有乳液の
任意濃度として、大腸菌及び黄色ブドウ球菌について
は、滅菌精製水で希釈した0.02wt%,0.2wt
%及び2.0wt%の3種類の濃度とし、MRSAにつ
いては、滅菌精製水で希釈した0.04wt%,0.4
wt%及び4.0wt%の3種類の濃度とした。 (2)「試験方法」 尚、1)使用した試験菌株、2)使用した増菌用培地及
び希釈用培地、3)使用した感受性測定用培地は、実施
例1によるD−リモネン単体を検体として用いた場合と
同じであって、次に示すように、4)感受性測定用平板
の調製仕様が異なる。 4)感受性測定用平板の調製 滅菌精製水を溶媒として用いてD−リモネン含有乳液
(検体)の40%(wt(溶質)/vol(溶媒))溶
液を調製した後、この溶液をもとにさらに2倍希釈系列
液を調製した。これらを均一に溶解させた後、約50℃
に保った上記感受性測定用培地に対し各希釈液をそれぞ
れ1/9量加えて充分に混合した後、複数のシャーレに
分注し、それぞれを固化させて感受性測定用平板とし
た。同様に、試験対照サンプルとして検体無添加の平板
も調製した。また、5)接種用菌液の調製仕様、6)培
養仕様、7)判定手法も、実施例1によるD−リモネン
単体を検体として用いた場合と同じである。 8)判定結果 その判定結果を以下の表2に示す。表2からも明らかな
ように、大腸菌及び黄色ブドウ球菌については、D−リ
モネン含有乳液の濃度が、0.02wt%(D−リモネ
ン単体換算濃度=0.008wt%)及び0.2wt%
(D−リモネン単体換算濃度=0.08wt%)の場合
はいずれの菌についても、その発育を阻止できず、抗菌
性が認められなかった。しかしながら、2.0wt%
(D−リモネン単体換算濃度=0.8wt%)の場合
は、その発育を阻止することができ、抗菌性が認められ
た。即ち、大腸菌及び黄色ブドウ球菌については、2.
0wt%のD−リモネン含有乳液濃度(D−リモネン単
体換算濃度=0.8wt%)を最小発育阻止濃度とし
た。
(1) "Test outline" This D-limonene-containing emulsion was diluted to an arbitrary concentration and added to an agar plate medium except that the above-mentioned D-limonene-containing emulsion was used as a sample instead of D-limonene alone. It is the same as in Example 1 that the minimum growth inhibitory concentration is defined as the lowest arbitrary concentration at which the growth of the bacteria can be inhibited after smearing the bacterial solution for inoculation and culturing. As an arbitrary concentration of the D-limonene-containing emulsion used for the measurement, for E. coli and Staphylococcus aureus, 0.02 wt% and 0.2 wt diluted with sterile purified water were used.
% And 2.0 wt%, and MRSA was diluted with sterile purified water at 0.04 wt% and 0.4 wt%.
Three types of concentrations, wt% and 4.0 wt%, were used. (2) "Test method" In addition, 1) the test strain used, 2) the culture medium for enrichment and the culture medium used for dilution, and 3) the culture medium for sensitivity measurement used were D-limonene simple substance according to Example 1 as a sample. This is the same as when it was used, and as described below, 4) the preparation specifications of the plate for sensitivity measurement are different. 4) Preparation of Plate for Sensitivity Measurement After preparing a 40% (wt (solute) / vol (solvent)) solution of a D-limonene-containing emulsion (sample) using sterile purified water as a solvent, based on this solution Furthermore, a 2-fold dilution series solution was prepared. After dissolving these uniformly, about 50 ℃
After adding 1/9 amount of each diluted solution to the above-mentioned susceptibility-measuring medium and thoroughly mixing, the mixture was dispensed into a plurality of petri dishes, and each was solidified to obtain a susceptibility-measuring plate. Similarly, a plate without a sample was prepared as a test control sample. The 5) preparation specifications of the inoculum bacterial solution, 6) culture specifications, and 7) determination method are also the same as when using D-limonene simple substance according to Example 1 as a sample. 8) Judgment result The judgment result is shown in Table 2 below. As is clear from Table 2, for Escherichia coli and Staphylococcus aureus, the concentration of the emulsion containing D-limonene was 0.02 wt% (D-limonene simplex conversion concentration = 0.008 wt%) and 0.2 wt%.
In the case of (concentration of D-limonene simple substance conversion = 0.08 wt%), the growth of any of the bacteria could not be prevented and no antibacterial property was observed. However, 2.0 wt%
In the case of (concentration of D-limonene simple substance conversion = 0.8 wt%), its growth was able to be inhibited and antibacterial property was recognized. That is, for E. coli and Staphylococcus aureus, 2.
The concentration of 0 wt% D-limonene-containing emulsion (D-limonene simple substance conversion concentration = 0.8 wt%) was defined as the minimum inhibitory concentration.

【0015】一方、MRSAについては、D−リモネン
含有乳液の濃度が、0.04wt%(D−リモネン単体
換算濃度=0.016wt%)及び0.4wt%(D−
リモネン単体換算濃度=0.16wt%)の場合は、そ
の発育を阻止できず、抗菌性が認められなかった。しか
し、4.0wt%(D−リモネン単体換算濃度=1.6
wt%)の場合は、その発育を阻止することができ、抗
菌性が認められた。即ち、MRSAについては、4.0
wt%のD−リモネン含有乳液濃度(D−リモネン単体
換算濃度=1.6wt%)を最小発育阻止濃度とした。
On the other hand, regarding MRSA, the concentrations of the emulsion containing D-limonene are 0.04 wt% (concentration converted to D-limonene simple substance = 0.016 wt%) and 0.4 wt% (D-limonene).
In the case of limonene simple substance conversion concentration = 0.16 wt%), its growth could not be prevented and no antibacterial property was observed. However, 4.0 wt% (D-limonene simple substance conversion concentration = 1.6
In the case of (wt%), its growth could be inhibited and antibacterial properties were recognized. That is, for MRSA, 4.0
The concentration of the milk emulsion containing D-limonene at wt% (concentration in terms of simple substance of D-limonene = 1.6 wt%) was defined as the minimum inhibitory concentration.

【0016】[0016]

【表2】 [Table 2]

【0017】尚、本参考例のD−リモネン含有乳液を被
消毒部にスプレーで吹きつけた後、布で擦拭するように
してもよい。即ち、D−リモネン含有乳液は、水系ミセ
ル内での汚染物への転移性並びに溶解性が良好であるの
で汚れ落としの効果が比較的良く、被消毒部の殺菌と殺
菌後の抗菌性を有するのは勿論のこと、衛生面と清掃面
の両面で効果を発揮する。
The D-limonene-containing milky lotion of this reference example may be sprayed on the portion to be disinfected and then wiped with a cloth. That is, since the D-limonene-containing emulsion has good transferability and solubility to contaminants in the aqueous micelle, it has a relatively good stain-removing effect, and has sterilization of the disinfected area and antibacterial properties after sterilization. Of course, it is effective both in terms of hygiene and cleaning.

【0018】また、上記参考例では、D−リモネン含有
乳液中の柑橘皮油濃度を40.5wt%とした例を示し
たが、表2の試験結果からも明らかなように、上記柑橘
皮油の添加量を例えば4.0wt%程度にした場合で
も、MRSAに対しても抗菌性のある乳液を得ることが
できる。このように柑橘皮油が比較的低濃度である場合
は、基材(精製水)に対する相溶性の面で少ない添加量
の乳化剤で済むこと、D−リモネン自体の可燃性による
危険度を小さくできること、或いは製品洗剤から発せら
れるD−リモネン特有の臭気がきつくないこと等の利点
をも有することとなる。
Further, in the above-mentioned reference example, the citrus peel oil concentration in the D-limonene-containing emulsion was set to 40.5 wt%, but as is clear from the test results in Table 2, the above citrus peel oil was used. Even when the addition amount of is about 4.0 wt%, an emulsion having antibacterial properties against MRSA can be obtained. When the citrus peel oil has a relatively low concentration as described above, a small amount of the emulsifier needs to be added in terms of compatibility with the base material (purified water), and the risk of the flammability of D-limonene itself can be reduced. Alternatively, it also has an advantage that the odor peculiar to D-limonene emitted from the product detergent is not tight.

【0019】以上述べたように、上記実施例の抗菌性持
続型消毒剤及び上記参考例のD−リモネン含有乳液は、
リモネンを香料の主用途として用いるのではなく、比較
的容易且つ多量に入手し得る柑橘皮油(D−リモネンを
多量含有)が備えたフィトンチッド性(植物が本来有す
る虫や菌を滅殺したり寄せつけたりしない特性)の優れ
た殺菌性及び抗菌性と、人体に対する安全性とを活用し
たものである。
As described above, the antibacterial persistent disinfectant of the above example and the D-limonene-containing emulsion of the above reference example are
Rhythmone is not used as the main use of fragrance, but it is relatively easy and available in large quantities. Citrus peel oil (containing a large amount of D-limonene) has a phytoncide property (kills or attracts insects and fungi originally possessed by plants). It has excellent bactericidal and antibacterial properties, which is a characteristic that does not occur, and safety for the human body.

【0020】[0020]

【発明の効果】本発明は抗菌性持続型消毒剤に係るもの
であって、被消毒部の殺菌性及び抗菌性を備えているの
はもとより、殺菌消毒後の被消毒部における抗菌性を長
期間持続し得る消毒剤に関するものである。従って、本
発明の抗菌性持続型消毒剤の実現によって、家庭内から
病院内に至るまで広範囲に亘り細菌類に対する殺菌・抗
菌効果を奏することができ、特に近年社会問題化してい
るMRSAに対する殺菌・抗菌効果は絶大である。
INDUSTRIAL APPLICABILITY The present invention relates to an antibacterial persistent disinfectant, which not only has the sterilizing property and antibacterial property of the disinfected area, but also has a long antibacterial property in the disinfected area after sterilization. It relates to a disinfectant that can last for a period of time. Therefore, the realization of the antibacterial and sustained disinfectant of the present invention can exert a bactericidal and antibacterial effect against bacteria in a wide range from home to hospital, and especially against sterilization against MRSA which has become a social problem in recent years. The antibacterial effect is great.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 桃井 一英 和歌山県和歌山市小雑賀2丁目5番115号 本州興産株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Kazuhide Momoi 2-5115 Kosiga, Wakayama, Wakayama Honshu Kosan Co., Ltd.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 医療用殺菌剤とリモネンとを含んでなる
抗菌性持続型消毒剤。
1. An antibacterial persistent disinfectant comprising a medical disinfectant and limonene.
【請求項2】 上記リモネンが少なくとも全体の0.8
wt%以上含まれてなる請求項1に記載の抗菌性持続型
消毒剤。
2. The limonene is at least 0.8 of the total.
The antibacterial persistent disinfectant according to claim 1, wherein the antibacterial persistent disinfectant is contained in an amount of at least wt%.
【請求項3】 上記医療用殺菌剤が常温下又は体温下で
蒸発するものである請求項1又は請求項2のいずれかに
記載の抗菌性持続型消毒剤。
3. The antibacterial continuous disinfectant according to claim 1, wherein the medical bactericidal agent evaporates at room temperature or body temperature.
JP5042703A 1993-03-03 1993-03-03 Antibacterial action-sustaining disinfectant Pending JPH06256104A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5042703A JPH06256104A (en) 1993-03-03 1993-03-03 Antibacterial action-sustaining disinfectant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5042703A JPH06256104A (en) 1993-03-03 1993-03-03 Antibacterial action-sustaining disinfectant

Publications (1)

Publication Number Publication Date
JPH06256104A true JPH06256104A (en) 1994-09-13

Family

ID=12643427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5042703A Pending JPH06256104A (en) 1993-03-03 1993-03-03 Antibacterial action-sustaining disinfectant

Country Status (1)

Country Link
JP (1) JPH06256104A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008531718A (en) * 2005-03-02 2008-08-14 カッティング・エッジ・フォーミュレーションズ・インコーポレーテッド Limonene-containing herbicide composition, herbicide stock formulation, and methods for making and using them
KR20180090916A (en) * 2017-02-03 2018-08-14 계명대학교 산학협력단 Natural antibacterial composition using food by-product and method for manufacturing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5046843A (en) * 1973-01-15 1975-04-25
JPS62111675A (en) * 1985-11-08 1987-05-22 Sanraku Inc Food preservative
JPS63159302A (en) * 1986-12-23 1988-07-02 Nittec Co Ltd Germicide and disinfectant
JPH04159201A (en) * 1990-10-19 1992-06-02 Meiji Yakuhin Kogyo Kk Antiseptic and mildewproofing material having evaporating property

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5046843A (en) * 1973-01-15 1975-04-25
JPS62111675A (en) * 1985-11-08 1987-05-22 Sanraku Inc Food preservative
JPS63159302A (en) * 1986-12-23 1988-07-02 Nittec Co Ltd Germicide and disinfectant
JPH04159201A (en) * 1990-10-19 1992-06-02 Meiji Yakuhin Kogyo Kk Antiseptic and mildewproofing material having evaporating property

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008531718A (en) * 2005-03-02 2008-08-14 カッティング・エッジ・フォーミュレーションズ・インコーポレーテッド Limonene-containing herbicide composition, herbicide stock formulation, and methods for making and using them
KR20180090916A (en) * 2017-02-03 2018-08-14 계명대학교 산학협력단 Natural antibacterial composition using food by-product and method for manufacturing the same

Similar Documents

Publication Publication Date Title
EP1278420B1 (en) Antimicrobial composition formulated with essential oils
US5403587A (en) Disinfectant and sanitizing compositions based on essential oils
US20090035339A1 (en) Methods of Inactivating Viruses
JP2014530176A (en) Disinfecting compositions and their use
CN108391673A (en) A kind of preparation method of nano silver/quaternary ammonium salt compound disinfectant
CN110477792A (en) A kind of nonalcoholic wet tissue and preparation method thereof can be used for breathing mask cleaning-sterilizing
JP3933714B2 (en) Glutaraldehyde composition
JPH072615A (en) Cloth impregnated with antimicrobial disinfectant
JPH05124910A (en) Sterilizing and disinfecting liquid and sterilizing and disinfecting material containing the same
JP2506125B2 (en) Sterilizing and softening composition
CN1142264C (en) Completely water-soluble hand-washing film
JPH06256104A (en) Antibacterial action-sustaining disinfectant
EP3764975B1 (en) A sanitizer composition
JPH06256792A (en) Antimicrobial cleansing agent for medicinal use
RU2355392C2 (en) Method of inhibiting antibiotic-resistant bacteria growth by using pentan-1,5-diol
JPH07252105A (en) Liquid disinfectant
HU226400B1 (en) Disinfectant compound based on didecyl dimethyl ammonium bromide carbamide clathrate
JP2003319887A (en) Sterilizing wet tissue and method for manufacturing the same
RU2125467C1 (en) Disinfectant agent "veltosept"
CN106137800A (en) Eucalyptus oil pasteurization towelette and preparation method thereof
WO2021260662A1 (en) Non-alcoholic antiseptic gel consists of benzalkonium chloride
JPS6344505A (en) Germicidal mildewproofing agent
JPH06253741A (en) Antimicrobial throat candy
KR20040098400A (en) Healthcare hand,skinwashing compositions
CN118252760A (en) Sterilizing wet tissue and preparation method thereof